ArticleJournal of translational medicine2025

Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer.

Gui-Xia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.